Category: GLP-1 RAs (Drug)

Ozempic Maker’s Stock Plunges 20% After Profit Warning

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.
America’s Whey Protein Obsession Is Transforming the Dairy Industry

Whey, the liquid byproduct of cheese making, was once considered waste. Now it is a key ingredient in the protein powders that Ozempic users and weight lifters are downing in ever-greater amounts.
What Katie Sturino Wants You to Know About Her Body (and Yours, Too)

The influencer is still pushing brands to make bigger sizes and is publishing a new novel with a plus-size heroine. She is also losing weight, but that doesn’t mean she’s not “body neutral” anymore.
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
Nine Federally Funded Scientific Breakthroughs That Changed Everything

The U.S. is slashing funding for scientific research, after decades of deep investment. Here’s some of what those taxpayer dollars created.
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
How Ozempic is Shaping Weddings

Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.
With Khloud, Khloe Kardashian Will Release a Protein-Packed Popcorn

Social media has fueled a “proteinification” of snacks, and Khloé Kardashian is hopping on board with a line of enhanced popcorn.
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.